Expertos Invitados





DOENÇA CARDIOVASCULAR E TRANSPLANTE RENAL

(especial para SIIC © Derechos reservados)
Desafios para a redução do risco de complicações cardiovasculares em pacientes com IRC incluem desde melhor estratificação de risco clínica e laboratorial até estratégias para prevenção e tratamento da doença cardiovascular.
wolff9.jpg Autor:
Luís henrique Wolff gowdak
Columnista Experto de SIIC
Artículos publicados por Luís henrique Wolff gowdak
Coautores
Flávio Jota de Paula* José Jayme Galvão De Lima** 
MD, Universidade de São Paulo, São Paulo, Brasil*
MD, PhD, Universidade de São Paulo, São Paulo, Brasil**
Recepción del artículo
1 de Noviembre, 2006 		Aprobación
4 de Enero, 2007
Primera edición
16 de Febrero, 2007 		Segunda edición, ampliada y corregida
7 de Junio, 2021

DOENÇA CARDIOVASCULAR E TRANSPLANTE RENAL

Resumen
Pacientes com insuficiência renal crônica constituem um dos grupos de mais alto risco para complicações cardiovasculares graves. Assim, a avaliação clínica cuidadosa de pacientes candidatos a transplante renal, com ênfase na detecção de doença arterial coronária (DAC), é etapa crucial para se assegurar evolução segura no período pós-transplante. Entre os desafios de otimização de estratégias para a redução do risco de complicações cardiovasculares nesta população, destacam-se: validação prospectiva de sistema de estratificação de risco clínica, o que levaria à identificação de pacientes que merecem estratificação adicional (não-invasiva ou invasiva); a escolha de métodos com elevada sensibilidade/especificidade nesta população e em quais subgrupos devem ser empregados; e, finalmente, melhores estratégias para prevenção e tratamento da doença cardiovascular e eventos associados. Neste trabalho, procuraremos discutir criticamente estes pontos através de revisão da literatura ou da experiência acumulada pelo nosso grupo. Somente olhando criticamente para a doença cardiovascular em candidatos a transplante renal, é que poderemos identificar novos desafios e reduzir a incidência de eventos após o transplante renal, permitindo maior sobrevida aos transplantados renais.

Palabras clave
insuficiência renal crônica, diálise, doença cardiovascular, risco, transplante renal


Artículo completo
(castellano)
Extensión:  +/-6.26 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

A CRITICAL VIEW OF CORONARY ARTERY DISEASE IN RENAL TRANSPLANT CANDIDATES - IDENTIFYING MAJOR CHALLENGES

Abstract
Patients with end-stage renal disease (ESRD) are one of the highest-risk groups for serious cardiovascular events. So, careful clinical assessment of renal transplant candidates, with special interest in the detection of significant coronary artery disease, is a crucial step to warrant a better long-term outcome after transplantation. Major challenges for greater reduction in the incidence of cardiovascular complications in this special population include: prospective validation of clinical risk stratification tools, leading to the identification of patients in whom additional workup may be needed (either non-invasive or invasive); selection of diagnostic methods with elevated sensitivity/specificity; and, finally, better therapeutic strategies for prevention and treatment of cardiovascular disease and comorbidities in patients with ESRD. In this paper, we will critically discuss those issues by reviewing the current literature and our own experience in the field. It is only through a critical appraisal of cardiovascular disease in renal transplant candidates that we will be able to identifiy new challenges in order to reduce the incidence of cardiovascular events after renal transplantation, yielding a better long-term survival.

Key words
chronic kidney disease, dialysis, cardiovascular disease, risk, renal transplantation

Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Trasplantes
Relacionadas: Cardiología, Diagnóstico por Laboratorio, Medicina Interna, Nefrología y Medio Interno



Comprar este artículo
Extensión: 6.26 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Luís Henrique Wolff Gowdak, Instituto do Coração (InCor) do Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, 05403-000, Av. Dr. Enéas de Carvalho Aguiar 44, São Paulo, Brasil
Bibliografía del artículo
1. 2005 United States Renal Data System (USRDS) Annual Report. Available at: www.usrds.org. Acessado em 02 de outubro de 2006.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
3. Schulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13(5 Suppl):I80-I93.
4. Pozzoni P, Del Vecchio L, Pontoriero G, Di Filippo S, Locatelli F. Long-term outcome in hemodialysis: morbidity and mortality. J Nephrol 2004; 17(Suppl 8):S87-S95.
5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.
6. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57:307-313.
7. Kasiske BL. Ischemic heart disease after renal transplantation. Kidney Int 2002; 61:356-360.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEPT) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
9. Le A, Wilson R, Douek K, et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994; 24:65-71.
10. Kassiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant 2001; 1(Suppl 2):44-52.
11. Medical Expert Group. V Clinical algorithms on cardiovascular risk factors in renal patients. Nephrol Dial Transplant 2000; 15(Suppl 5):144-145.
12. Lewis MS, Wilson RA, Walker KW, et al. Validation of algorithm for predicting cardiac events in renal transplant candidates. Am J Cardiol 2002; 89:847- 850.
13. Gowdak LH, De Paula FJ, Giorgi DMA, Vieira MLC, Krieger EM, De Lima JJG. Cardiovascular disease and risk factors in candidates for renal transplantation. Arq Bras Cardiol 2005; 84:156-160.
14. Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986; 1:211-219.
15. American College of Physicians. Position paper. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Int Med 1997; 127:309-312.
16. De Lima JJG, Sabbaga E, Vieira MLC, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003; 42:263-268.
17. Schmidt A, Stefenelli T, Schuster T, Mayer G. Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 2001; 37:46-63.
18. Holley JJ, Fenton RA, Arthur RS. Thalium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 1991; 90:563-570.
19. Reis G, Marcovitz PA, Leitchman AB, et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 1995; 75:707-710.
20. De Lima JJG, Gowdak LHW. Coronary artery disease and end-stage renal disease - a clinical perspective. Curr Hypertens Reviews 2006; 2:139-145.
21. Andrade JM, Rochitte CE, Gowdak LHW, et al. Evaluation of myocardial ischemia by magnetic resonance myocardial stress perfusion in renal transplant candidates: Comparison with SPECT and coronary angiography. J Am Coll Cardiol 2004; 43(Suppl A):353A.
22. Andrade JM. Estudo de perfusão e viabilidade miocárdicas por ressonância magnética em pacientes com doença renal crônica candidatos a transplante renal. Tese (Doutoramento) (128p) - Faculdade de Medicina da Universidade de São Paulo, 2006.
23. Merz NB. Assessment of patients at intermediate cardiac risk. Am J Cardiol 2005; 96(Suppl):2J-10J.
24. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003; 41:159-168.
25. Fox K, Garcia MAL, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.
Eur Heart J 2006; 27:1341-1381.
26. Sociedade Brasileira de Cardiologia. Guidelines of chronic coronary disease: stable angina. Arq Bras Cardiol 2004; 83(Suppl 2):6-43.
27. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006; 296:1377-1384.
28. Opsahl JA, Husebye DG, Helseth HK, Collins AJ. Coronary artery bypass surgery in patients on maintenance dialysis: long-term survival. Am J Kidney Dis 1988; 12:271-274.
29. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003; 92:509-514.
30. Chertow GM, Normand SL, Silva LR, McNeil BJ. Survival after myocardial infarction in patients with end-stage renal disease: results from cooperative cardiovascular project. Am J Kidney Dis 2000; 35:1044-1051.
31. Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340:998-1002.
32. McCullough PA. Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease. Adv Chronic Kidney Dis 2004; 11:294-303.
33. Martirosyan HA, Brass EP, Mehrotra R, Adler SG; Cardio-Renal Responder Group and the Validation Cohort. Differential management of cardiovascular disease in ESRD by nephrologists and cardiologists. Am J Kidney Dis 2004; 44:309-321.
34. Miller LM, Hopman WM, Garland JS, Yeates KE, Pilkey RM. Cardioprotective medication use in hemodialysis patients. Can J Cardiol 2006; 22:755-760.
35. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation 2004; 109:2866-2871.
36. Saw J, Levin A, Gin K. Coronary artery disease in chronic kidney disease patients: assessing the evidence for diagnosis, screening and revascularization. Can J Cardiol 2004; 20:807-813.
37. Ix JH, Mercado N, Shlipak MG, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J 2005; 149:512-519.
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008